62 related articles for article (PubMed ID: 20030517)
1. Synthesis and activity of amides of tripeptides as potential urokinase inhibitors.
Markowska A; Bruzgo I; Midura-Nowaczek K
J Enzyme Inhib Med Chem; 2010 Feb; 25(1):139-42. PubMed ID: 20030517
[TBL] [Abstract][Full Text] [Related]
2. Tripeptides with non-code amino acids as potential serine proteases inhibitors.
Markowska A; Bruzgo M; Surażyński A; Midura-Nowaczek K
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Activity of
Markowska A; Bruzgo M; Gorodkiewicz E; Surażyński A
Int J Pept Res Ther; 2013; 19(3):191-198. PubMed ID: 23926446
[TBL] [Abstract][Full Text] [Related]
4. Development of irreversible diphenyl phosphonate inhibitors for urokinase plasminogen activator.
Joossens J; Van der Veken P; Lambeir AM; Augustyns K; Haemers A
J Med Chem; 2004 May; 47(10):2411-3. PubMed ID: 15115382
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of peptide inhibitors of blood coagulations.
Bajusz S; Széll E; Barabás E; Bagdy D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):16-21. PubMed ID: 6177598
[TBL] [Abstract][Full Text] [Related]
6. Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: optimization of the P4 position.
Joossens J; Van der Veken P; Surpateanu G; Lambeir AM; El-Sayed I; Ali OM; Augustyns K; Haemers A
J Med Chem; 2006 Sep; 49(19):5785-93. PubMed ID: 16970403
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and activity of N-sulfonylamides of tripeptides as potential urokinase inhibitors.
Markowska A; Bruzgo I; Miltyk W; Midura-Nowaczek K
Protein Pept Lett; 2010 Oct; 17(10):1300-4. PubMed ID: 20594155
[TBL] [Abstract][Full Text] [Related]
8. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
9. Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
Hijikata A; Okamoto S; Kikumoto R; Tamao Y
Thromb Haemost; 1979 Oct; 42(3):1039-45. PubMed ID: 159513
[TBL] [Abstract][Full Text] [Related]
10. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
Yomtova VM; Stambolieva NA; Blagoev BM
Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
[TBL] [Abstract][Full Text] [Related]
11. Development of plasma kallikrein selective inhibitors.
Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
[TBL] [Abstract][Full Text] [Related]
12. 4-amidinobenzylamine-based inhibitors of urokinase.
Künzel S; Schweinitz A; Reissmann S; Stürzebecher J; Steinmetzer T
Bioorg Med Chem Lett; 2002 Feb; 12(4):645-8. PubMed ID: 11844691
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
Gilboa N; Villannueva GB; Fenton JW
Enzyme; 1988; 40(2-3):144-8. PubMed ID: 2971531
[TBL] [Abstract][Full Text] [Related]
14. Effects of epsilon-aminocaproiloaminoacids on the amidolytic activity of tissue plasminogen activator, urokinase and kallikrein.
Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Markowska A
Acta Pol Pharm; 2004; 61(1):75-6. PubMed ID: 15259861
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of selected insect neuropeptide analogs modified by D- or L-phenylglycine derivatives.
Szeszel-Fedorowicz W; Rosiński G; Issberner J; Osborne R; Janssen I; De Loof A; Konopińska D
Acta Pol Pharm; 2000 Nov; 57 Suppl():88-9. PubMed ID: 11293277
[TBL] [Abstract][Full Text] [Related]
16. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
Pućkowska A; Midura-Nowaczek K; Bruzgo I
Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of alkylamides of dipeptides as potential plasmin inhibitors.
Midura-Nowaczek K; Lepietuszko I; Bruzgo I
Acta Pol Pharm; 2006; 63(1):33-7. PubMed ID: 17515327
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA).
Venkatraj M; Messagie J; Joossens J; Lambeir AM; Haemers A; Van der Veken P; Augustyns K
Bioorg Med Chem; 2012 Feb; 20(4):1557-68. PubMed ID: 22285569
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of benzylamides of dipeptides as potential inhibitors of plasmin.
Midura-Nowaczek K; Roszkowska-Jakimiec W; Lepietuszko I; Bruzgo I
Pharmazie; 2003 Oct; 58(10):687-9. PubMed ID: 14609277
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.
Taitzoglou IA; Tsantarliotou M; Zervos I; Kouretas D; Kokolis NA
Reproduction; 2001 Jan; 121(1):131-7. PubMed ID: 11226036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
